GlassScriptPhysician profile
Bradly S Healton
NPI 1154337988
$482.90
in general payments reported to CMS, 2019-2025
9 companies · $188 in 2025
The $188 reported for 2025 was more than what 81% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $68.45 · 2024: $226 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $161.39 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $75.60 | 2023-2024 | Puraply |
| Reapplix INC. | $61.07 | 2025 | 3c Patch Kit - Box |
| Smith+Nephew, INC. | $55.16 | 2023-2024 | Collagenase Santyl, Regranex |
| Convatec INC. | $35.56 | 2023 | |
| Urgo Medical North America, LLC | $33.70 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Mimedx Group, INC. | $22.17 | 2025 | |
| Hartmann USA, INC. | $20.81 | 2025 | Zetuvit Plus 10x10 P10 |
| Reprise Biomedical, INC. | $17.44 | 2025 | Miro 3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradly Healton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.